The urea breath test is a non-invasive diagnostic test used to detect the presence of the bacteria Helicobacter pylori (H. pylori) in the stomach and duodenum. It involves ingesting urea that is labelled with carbon-13, a non-radioactive isotope of carbon, which is then broken down by urea present in the stomach. If H. pylori is present, it produces urease which breaks down the urea, producing carbon dioxide that is exhaled in the breath. Measurement of the carbon-13 level in exhaled breath using isotope ratio mass spectrometry can detect the presence or absence of H. pylori infection. The Urea Breath Test (UBT) is recommended as the primary test for patients in developed countries and offers higher accuracy than stool antigen tests or serum antibody tests.
The global Urea Breath Test Market is estimated to be valued at US$ 140.8 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The global Urea Breath Test Market is expected to witness high growth over the forecast period, 2024 to 2031, driven by the rising prevalence of H. pylori infections worldwide. According to the National Institute of Diabetes and Digestive and Kidney Diseases, around 35% of adults in the US are infected with H. pylori bacteria. High prevalence of bacterial infections are attributable to factors such as consumption of contaminated food and water. Moreover, growing awareness about early diagnosis of H. pylori infections is also propelling the demand for diagnostic tests like Urea Breath Tests. However, high costs associated with UBT systems and skilled professionals required for conducting the tests are some of the factors expected to hamper market growth over the forecast period.
SWOT Analysis
Strength: The urea breath test market has widespread adoption rates, as it is a non-invasive and affordable way to detect Helicobacter pylori infections. It provides rapid results within minutes, allowing for quick diagnosis and treatment. The procedure is also comfortable for patients as it does not require fasting or sedation.
Weakness: The accuracy of urea breath tests depends highly on patient compliance and proper administration of the test. If patients do not follow pre-test instructions properly or have other medical conditions, it can yield inaccurate results. The tests also have limitations in detecting recently acquired or antibiotic-treated H. pylori infections.
Opportunity: With rising awareness about H. pylori infections and their link to various gastrointestinal diseases, the demand for diagnostic testing is increasing globally. Market players can leverage this to promote the urea breath test as a front-line diagnostic option. Growing geriatric populations also present an opportunity, as older adults are at higher risk of H. pylori infections.
Threats: Other emerging diagnostic methods like stool antigen tests and blood antibody tests are gaining traction due to their ease of use and convenient sample collection methods. Strict regulations surrounding medical device approval processes can also delay the launch of new product innovations. Rising healthcare costs are increasing the pricing pressures on market players.
Key Takeaways
The Global Urea Breath Test Market Size is expected to witness high growth over the forecast period of 2024 to 2031. At a projected CAGR of 6.6%, the market size will increase from US$ 140.8 Mn in 2023to US$ 228.8 Mn by 2031.
Regional analysis: North America currently dominates the market owing to advanced healthcare infrastructure and widespread diagnostic testing rates in the region. However, Asia Pacific is expected to showcase the fastest growth over the coming years. Factors such as the large patient population, increasing healthcare spending, and rising awareness about H. pylori infections are driving the APAC market.
Key players: Key players operating in the urea breath test market are Al Dahra ACX Global Inc., Alfalfa Monegros SL, Anderson Hay & Grain Inc., Border Valley, and Cubeit Hay Company. They are focusing on launching innovative product formats like portable handheld analyzers and kits for point-of-care testing. Partnerships with end users like hospitals and diagnostic labs are also a key strategic focus.
Get more insights on this topic: https://www.newsstatix.com/urea-breath-test-market-share/
Check below trending articles on this topic: https://captionssky.com/bridging-nature-and-innovation-unravelling-the-wonders-of-synthetic-biologys-genetic-tapestry/
